Trials / Conditions / Squamous Cell Carcinoma of the Esophagus

Squamous Cell Carcinoma of the Esophagus

9 registered clinical trials studyying Squamous Cell Carcinoma of the Esophagus.

Status	Trial	Sponsor	Phase
Completed	A Study of KF-0210 in Advanced Solid Tumors Patients NCT04713891	Keythera Pharmaceuticals (Australia) Pty Ltd	Phase 1
Completed	Study With Paclitaxel +/- Ramucirumab in Patients With Squamous-cell Carcinoma of the Esophagus After Prior Th NCT03762564	Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest	Phase 2
Withdrawn	Assessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph NCT03307941	Jules Bordet Institute	Phase 1 / Phase 2
Completed	Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esop NCT01612546	City of Hope Medical Center	Phase 2
Completed	Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal NCT01212822	Fox Chase Cancer Center	Phase 2
Completed	Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have F NCT01129206	Ohio State University Comprehensive Cancer Center	Phase 2
Completed	Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydroch NCT01561014	Wake Forest University Health Sciences	Phase 1
Terminated	A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer NCT00064259	National Cancer Institute (NCI)	Phase 1 / Phase 2
Completed	Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer NCT00045526	National Cancer Institute (NCI)	Phase 2